View Clinical Trial (Medical Research Study)
A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated - NCT00233506-55905(Clinical Trial 131847)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Rochester |
|
State:
|
|
MN |
| Zip Code: |
|
55905 |
| Conditions: |
|
Chronic Lymphocytic Leukemia |
| Purpose: |
|
- CpG has the potential to stimulate the immune system
- this study will evaluate the safety of CpG given sub-q or IV
- purpose is to measure biological changes in CLL cells after receiving CpG
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Diagnosis of CLL
- CLL previously treated
- Hemoglobin >/= 10
- Platelets >/= 50,000
- Neutrophils >= 1,000 -
Exclusion Criteria:
- patients with brain mets
- patients with autoimmune disease
- patients on corticosteroids or immunosuppressants
- patients with uncontrolled intercurrent illness
- pregnant women
- HIV patients receiving combination anti-retroviral therapy |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 11, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|